coronary artery disease heart disease ischemic heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Age 18 years and over (there is no a priori upper age limit); (2) Documented stable CAD and referred to cardiac rehabilitation (at > 2 weeks but 4 weeks but 50%); (3) Access and ability to operate a smartphone; (4) Able to speak the country*s native language.
Exclusion criteria
Exclusion criteria: (1) Unable to fully understand the provided study information and consequences of participating in the study; (2) presence of a physical impairments interfering with the use of the app or devices (e.g., blindness, wheelchair bound); (3) known diagnosis of an active malignant tumors (cancer) or any other medical condition associated with an expected life expectancy of less than one year; (4) Unstable cardiovascular, cerebrovascular or other unstable medical conditions; (5) Refusal to informed consent; (6) Having a pacemaker.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To investigate whether the TIMELY intervention is superior to usual care in terms of A) reducing the CoroPredict risk score (indicating risk of 10-year mortality: primary biomedical outcome) from baseline to six months; and B) increasing functional fitness levels (6-minute walk test) primary behavioural outcome) from baseline to 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| The improvements under primary objectives are expected to be associated with improvements in the secondary outcomes: a. Physical activity levels and cardiovascular responses to exercise b. Healthy dietary habits c. Smoking cessation d. Medication adherence e. Reducing psychological stress levels 1. To investigate whether the TIMELY intervention is superior to care as usual in terms of improvement in physical and mental well-being and quality of life 2. To investigate the feasibility and usability of the TIMELY intervention. 3. To investigate whether the TIMELY intervention is superior to care as usual in terms of cost-effectiveness | — |
Countries
Netherlands